What is it about?
Biological material of human and nonhuman origin has been collected for decades, serving as source for research and education. The collection, processing, storage and dissemination of these biosamples are described with the term "biobanking", that follow strict regulatory schemes in each step of processing. Within these schemes one of the most important principles is the consent procedure, by which donors’ give their permission for future biosample and data processing. Exploring the evolution of consent forms and addressing many issues, limitations, barriers, current, and future challenges in research-related activities in biobanking sector, we represent an indicative point of view on how biobanks apprehend the present system, and what are the levels of readiness and/or willingness to change, by implementing novel technologies in the era of big data and digitalization.
Featured Image
Photo by CDC on Unsplash
Why is it important?
The present workshop proceedings, represent the real-world consent-related issues deal with organizations’ present and future perspectives, giving an insight of current problems that appears within the biobanking sector and creating a potential starting point for future research and development of innovative global system for informed consent procedures.
Perspectives
An intrigued and interactive workshop that set the light in the biobanking sector, representing a small but valuable insight of current and future needs and perspectives in biobanking sector.
Desislava Ivanova
Read the Original
This page is a summary of: Workshop Proceedings: Informed Consent in Biobanking–from the Key Barriers, Challenges, and Perceptions to Digital Innovations, Innovations in Digital Health Diagnostics and Biomarkers, January 2022, Innovative Healthcare Institute,
DOI: 10.36401/iddb-21-07.
You can read the full text:
Contributors
The following have contributed to this page
